Ovid Therapeutics Inc.

NASDAQ: OVID · Real-Time Price · USD
0.96
0.12 (14.24%)
At close: Aug 15, 2025, 3:59 PM
0.97
0.54%
After-hours: Aug 15, 2025, 07:58 PM EDT

Ovid Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.5 -4.34 -2.42 1.76
PEG Ratio
0.05 1.11 0.02 -0.01
PS Ratio
116.97 580.22 87.15 1.04
PB Ratio
0.97 2.59 0.99 1.21
P/FCF Ratio
-1.18 -4.95 -2.31 1.83
P/OCF Ratio
-1.18 -4.96 -2.37 1.83
OCF/S Ratio
-98.86 -116.88 -36.74 0.57
Debt / Equity Ratio
0.22 0.18 0.13 n/a
Quick Ratio
5.32 9.55 18.79 12.87
Current Ratio
5.32 9.55 18.79 12.87
Asset Turnover
0.01 0.00 0.01 1.07
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.39 -0.6 -0.41 0.68
Return on Assets
-0.29 -0.36 -0.35 0.63
Return on Invested Capital
-0.73 -0.44 -0.37 0.68
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 1.00 1.00
Net Profit Margin
-46.7 -133.62 -36.04 0.59
Pretax Profit Margin
-46.7 -133.62 -36.04 0.60
Operating Profit Margin
-109.34 -151.34 -36.96 0.60
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-102.07 -145.55 -36.04 0.60